Logo image of UXIN

UXIN LTD - ADR (UXIN) Stock Fundamental Analysis

NASDAQ:UXIN - Nasdaq - US91818X3061 - ADR - Currency: USD

4.75  +0.06 (+1.28%)

Fundamental Rating

1

UXIN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. UXIN may be in some trouble as it scores bad on both profitability and health. UXIN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year UXIN has reported negative net income.
In the past 5 years UXIN always reported negative net income.
UXIN had a negative operating cash flow in each of the past 5 years.
UXIN Yearly Net Income VS EBIT VS OCF VS FCFUXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -1B -2B -3B

1.2 Ratios

UXIN has a Return On Assets of -58.75%. This is amonst the worse of the industry: UXIN underperforms 94.02% of its industry peers.
Industry RankSector Rank
ROA -58.75%
ROE N/A
ROIC N/A
ROA(3y)-56.61%
ROA(5y)-47.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UXIN Yearly ROA, ROE, ROICUXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 3.45%, UXIN is doing worse than 95.73% of the companies in the same industry.
UXIN's Gross Margin has declined in the last couple of years.
UXIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.05%
GM growth 5Y-54.25%
UXIN Yearly Profit, Operating, Gross MarginsUXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

UXIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UXIN has been increased compared to 1 year ago.
Compared to 5 years ago, UXIN has more shares outstanding
UXIN has a worse debt/assets ratio than last year.
UXIN Yearly Shares OutstandingUXIN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
UXIN Yearly Total Debt VS Total AssetsUXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -8.93, we must say that UXIN is in the distress zone and has some risk of bankruptcy.
UXIN's Altman-Z score of -8.93 is on the low side compared to the rest of the industry. UXIN is outperformed by 94.02% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.93
ROIC/WACCN/A
WACC8.21%
UXIN Yearly LT Debt VS Equity VS FCFUXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B -2B

2.3 Liquidity

A Current Ratio of 0.39 indicates that UXIN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.39, UXIN is doing worse than 96.58% of the companies in the same industry.
A Quick Ratio of 0.14 indicates that UXIN may have some problems paying its short term obligations.
With a Quick ratio value of 0.14, UXIN is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.14
UXIN Yearly Current Assets VS Current LiabilitesUXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

UXIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.96%, which is quite impressive.
UXIN shows a strong growth in Revenue. In the last year, the Revenue has grown by 148.87%.
The Revenue has been growing by 14.69% on average over the past years. This is quite good.
EPS 1Y (TTM)67.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.93%
Revenue 1Y (TTM)148.87%
Revenue growth 3Y35.4%
Revenue growth 5Y14.69%
Sales Q2Q%44.16%

3.2 Future

Based on estimates for the next years, UXIN will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.81% on average per year.
Based on estimates for the next years, UXIN will show a very strong growth in Revenue. The Revenue will grow by 87.81% on average per year.
EPS Next Y-4475.5%
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue Next Year53.35%
Revenue Next 2Y137.9%
Revenue Next 3Y87.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UXIN Yearly Revenue VS EstimatesUXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
UXIN Yearly EPS VS EstimatesUXIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UXIN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UXIN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UXIN Price Earnings VS Forward Price EarningsUXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UXIN Per share dataUXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as UXIN's earnings are expected to decrease with -22.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%

More info and screens

0

5. Dividend

5.1 Amount

UXIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UXIN LTD - ADR

NASDAQ:UXIN (2/21/2025, 8:00:01 PM)

4.75

+0.06 (+1.28%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-25 2024-11-25/bmo
Earnings (Next)04-23 2025-04-23
Inst Owners0.03%
Inst Owner Change-99.89%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap892.75M
Analysts43.33
Price TargetN/A
Short Float %4.81%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-54.88%
Min Revenue beat(2)-58.49%
Max Revenue beat(2)-51.27%
Revenue beat(4)0
Avg Revenue beat(4)-34.85%
Min Revenue beat(4)-58.49%
Max Revenue beat(4)-0.49%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.07
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.45%
FCFM N/A
ROA(3y)-56.61%
ROA(5y)-47.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.05%
GM growth 5Y-54.25%
F-ScoreN/A
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.14
Altman-Z -8.93
F-ScoreN/A
WACC8.21%
ROIC/WACCN/A
Cap/Depr(3y)57.08%
Cap/Depr(5y)72.38%
Cap/Sales(3y)0.94%
Cap/Sales(5y)5.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.93%
EPS Next Y-4475.5%
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue 1Y (TTM)148.87%
Revenue growth 3Y35.4%
Revenue growth 5Y14.69%
Sales Q2Q%44.16%
Revenue Next Year53.35%
Revenue Next 2Y137.9%
Revenue Next 3Y87.81%
Revenue Next 5YN/A
EBIT growth 1Y26.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.45%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y67.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.28%
OCF growth 3YN/A
OCF growth 5YN/A